MOUNTAIN VIEW, Calif., Feb. 13, 2013 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, was recently honored by Microsoft as a worldwide Windows Embedded Partner Excellence Award recipient for intelligent systems healthcare solutions at the 2012 Intelligent Systems Leadership Summit held on the Microsoft campus in Redmond, Wash. (Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a) The Windows Embedded Partner Excellence Awards recognize members of the Windows Embedded Partner Program that excel at driving the Windows Embedded business and the development of intelligent systems worldwide. Intelligent systems represent the evolution of the embedded device market that enables data to flow across an enterprise infrastructure, spanning the devices where valuable data is gathered from employees and customers, to the back-end systems where that data can be translated into insights and action. "Omnicell is honored to be recognized by Windows Embedded as a key innovator for the emerging intelligent health systems market," said Marga Ortigas-Wedekind, executive vice president, global marketing and product development at Omnicell. "This award demonstrates our commitment to working with Microsoft to provide cutting edge solutions. Omnicell's G4 medication management system runs on the Windows Embedded Standard 7 operating system, which has empowered healthcare providers with improved security, a more streamlined Windows update process and long end-of-life and technical support." "Healthcare is a major industry that is benefitting from intelligent systems created by partners like Omnicell," said Valerie Olague, Windows Embedded business group lead, Americas at Microsoft. "We are excited to recognize Omnicell for their innovation in improving the healthcare environment and patient care alike." The Windows Embedded Partner Program is a strategic worldwide program that provides partners with increased business opportunities, market awareness and technology advice. For more information about the Windows Embedded Partner Program, visit: http://www.microsoft.com/windowsembedded/en-us/partners/About Omnicell For over 20 years the mission of Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.Since 1992, more than 2,600 Acute Care customers worldwide have utilized Omnicell's medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions that can reduce costly hospital readmissions and enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.For more information about Omnicell, Inc. please visit www.omnicell.com. OMCL - G
Since this summer's market low, small-cap stocks have been outperforming large-cap stocks. Here are small caps with 'persistently strong top-line growth and improving fundamentals,' according to RBC Capital Markets.